Fierce Biotech September 15, 2023
Beacon Biosignals is living out a dream scenario: Mere weeks after acquiring EEG headset maker Dreem, it has earned FDA clearance for a sleep monitoring solution that combines the Dreem hardware with Beacon’s own artificial intelligence-based software.
The sleep monitoring system is aimed not at doctors seeking to make one-off diagnoses off their patients’ sleep disorders, but at clinical research teams developing new treatments for a variety of brain-related conditions.
“Longitudinal EEG sleep data may be a powerful tool to gain clinical insight into a wide variety of neurological and psychiatric conditions,” Jacob Donoghue, M.D., Ph.D., Beacon’s CEO and co-founder, said in the company’s announcement Thursday. “We are enabling high-fidelity, overnight brain activity to be efficiently...
Today's Sponsors
Today's Sponsor